Laura Sepp-Lorenzino
2020
In 2020, Laura Sepp-Lorenzino earned a total compensation of $1.7M as Executive Vice President, Chief Scientific Officer at Intellia Therapeutics, a 4% decrease compared to previous year.
Compensation breakdown
| Bonus | $184,800 |
|---|---|
| Option Awards | $1,081,148 |
| Salary | $420,000 |
| Other | $4,578 |
| Total | $1,690,526 |
Sepp-Lorenzino received $1.1M in option awards, accounting for 64% of the total pay in 2020.
Sepp-Lorenzino also received $184.8K in bonus, $420K in salary and $4.6K in other compensation.
Rankings
In 2020, Laura Sepp-Lorenzino's compensation ranked 6,308th out of 13,090 executives tracked by ExecPay. In other words, Sepp-Lorenzino earned more than 51.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,308 out of 13,090 | 52nd |
Division Manufacturing | 2,600 out of 5,624 | 54th |
Major group Chemicals And Allied Products | 1,047 out of 2,257 | 54th |
Industry group Drugs | 904 out of 1,957 | 54th |
Industry In Vitro and In Vivo Diagnostic Substances | 13 out of 60 | 78th |
Source: SEC filing on May 2, 2022.
Sepp-Lorenzino's colleagues
We found three more compensation records of executives who worked with Laura Sepp-Lorenzino at Intellia Therapeutics in 2020.